Chan‐Keng Yang
Impact in
-
- Cancer Immunotherapy and Biomarkers
- Dermatology top 10%
- Chemotherapy-related skin toxicity
Papers in
- Oncology 11
- Cancer Immunotherapy and Biomarkers 6
- Global Cancer Incidence and Screening 2
- CAR-T cell therapy research 2
-
- Immunotherapy and Immune Responses 3
- T-cell and B-cell Immunology 2
- Co-authors
- Meng‐Ting Peng (4 shared papers)Chun‐Bing Chen (3 shared papers)Ming-Ying Wu (1 shared paper)Shun‐Fa Yang (1 shared paper)Chen‐Yang Huang (2 shared papers)Pei‐Han Kao (1 shared paper)Wen‐Hung Chung (2 shared papers)Rosaline Chung‐Yee Hui (1 shared paper)
- Journals
- BMC Cancer (2 papers)Hepatology (2 papers)Cancer Management and Research (1 paper)Nature Communications (1 paper)Frontiers in Oncology (1 paper)
- Partner nations
- TaiwanChinaUnited States
In The Last Decade
Chan‐Keng Yang
21 papers receiving 344 citations
Peers
Comparison fields: 5 of 38
- Oncology 127
- Dermatology 41
- Pharmacology 66
- Hepatology 18
- Otorhinolaryngology 10
Countries citing papers authored by Chan‐Keng Yang
This map shows the geographic impact of Chan‐Keng Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chan‐Keng Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chan‐Keng Yang more than expected).
Fields of papers citing papers by Chan‐Keng Yang
This network shows the impact of papers produced by Chan‐Keng Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chan‐Keng Yang. The network helps show where Chan‐Keng Yang may publish in the future.
Co-authors
The 25 scholars most cited alongside Chan‐Keng Yang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 129 | |
| 2 | 2020 | 36 | |
| 3 | 2022 | 24 | |
| 4 | 2020 | 18 | |
| 5 | 2020 | 17 | |
| 6 | 2022 | 17 | |
| 7 | 2024 | 17 | |
| 8 | 2023 | 14 | |
| 9 | 2020 | 12 | |
| 10 | 2020 | 12 | |
| 11 | 2018 | 10 | |
| 12 | 2023 | 9 | |
| 13 | 2023 | 8 | |
| 14 | 2015 | 6 | |
| 15 | 2025 | 6 | |
| 16 | 2016 | 5 | |
| 17 | 2022 | 4 | |
| 18 | 2024 | 4 | |
| 19 | 2023 | 3 | |
| 20 | 2017 | 1 |
About Chan‐Keng Yang
Chan‐Keng Yang is a scholar working on Oncology, Immunology, Pharmacology, Surgery and Cardiology and Cardiovascular Medicine, having authored 21 papers that have together received 353 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (6 papers), Drug-Induced Adverse Reactions (3 papers), Esophageal Cancer Research and Treatment (3 papers), Immunotherapy and Immune Responses (3 papers), Global Cancer Incidence and Screening (2 papers), T-cell and B-cell Immunology (2 papers), CAR-T cell therapy research (2 papers) and Acute Myocardial Infarction Research (2 papers). The work is most often cited by research in Oncology (127 citations), Dermatology (41 citations), Pharmacology (66 citations), Hepatology (18 citations) and Otorhinolaryngology (10 citations). Chan‐Keng Yang has collaborated with scholars based in Taiwan, China and United States. Frequent co-authors include Meng‐Ting Peng, Chun‐Bing Chen, Ming-Ying Wu, Shun‐Fa Yang, Chen‐Yang Huang, Pei‐Han Kao, Wen‐Hung Chung, Rosaline Chung‐Yee Hui, Jennifer Wu and Chau Yee Ng. Their work appears in journals such as BMC Cancer, Hepatology, Cancer Management and Research, Nature Communications and Frontiers in Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.